# P2.01-46 The Efficacy and Safety of 2nd-Line Nivolumab for Non-Small Cell Lung Cancer in Real-World Practice with Emphasis on Hyperprogession

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/p2-01-46-the-efficacy-and-safety-of-2nd-line-nivolumab-for-non-small-cell-lung/

## Facts

| Field | Value |
| --- | --- |
| Author Names | J.C. Lee,Chang‐Min Choi,Wonjun Ji,S.H. Kim |
| Citations | 2 |
| DOI | 10.1016/j.jtho.2019.08.1389 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.jto.org/article/S1556086419320726/pdf |
| OpenAlex ID | https://openalex.org/W2982077589 |
| Type | article |
| Year | 2019 |

## Paper authors

- [J.C. Lee](https://scholariq.org/researchers/j-c-lee/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Diagnosis and Treatment](https://scholariq.org/topics/cancer-diagnosis-and-treatment/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.